These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 9593063

  • 21. Comparative effects of type 1 angiotensin II-receptor blockade with angiotensin-converting-enzyme inhibitor on left ventricular distensibility and collagen metabolism in spontaneously hypertensive rats.
    Yonezawa T, Umemoto S, Fujii A, Katayama K, Matsuzaki M.
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):119-24. PubMed ID: 8656644
    [Abstract] [Full Text] [Related]

  • 22. [Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
    Mill JG, Milanez Mda C, Busatto VC, de Moraes AC, Gomes Mda G.
    Arq Bras Cardiol; 1997 Aug; 69(2):101-10. PubMed ID: 9567332
    [Abstract] [Full Text] [Related]

  • 23. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
    Jugdutt BI, Lucas A, Khan MI.
    Can J Cardiol; 1997 Jul; 13(7):657-68. PubMed ID: 9251578
    [Abstract] [Full Text] [Related]

  • 24. Effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction: a possible mechanism of prevention of cardiac events by angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk myocardial infarction.
    Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, Iida K, Matsumoto M, Kumabe N, Onikura M, Hirayama A.
    Intern Med; 2009 Jul; 48(11):877-82. PubMed ID: 19483355
    [Abstract] [Full Text] [Related]

  • 25. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J.
    J Am Coll Cardiol; 2003 Nov 05; 42(9):1666-73. PubMed ID: 14607457
    [Abstract] [Full Text] [Related]

  • 26. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY, Huang YL, Sun YH.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 20; 85(15):1053-6. PubMed ID: 16029550
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R, Young SD, Strosberg AM.
    J Cardiovasc Pharmacol; 1994 Feb 20; 23(2):291-9. PubMed ID: 7511760
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
    Tokioka-Akagi T, Fujimori A, Shibasaki M, Inagaki O, Yanagisawa I.
    Jpn J Pharmacol; 2001 May 15; 86(1):79-85. PubMed ID: 11430476
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin II receptor binding following myocardial infarction in the rat.
    Sun Y, Weber KT.
    Cardiovasc Res; 1994 Nov 15; 28(11):1623-8. PubMed ID: 7842454
    [Abstract] [Full Text] [Related]

  • 34. Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility.
    Thai HM, Van HT, Gaballa MA, Goldman S, Raya TE.
    Am J Physiol; 1999 Mar 15; 276(3):H873-80. PubMed ID: 10070070
    [Abstract] [Full Text] [Related]

  • 35. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
    Xu X, Wan W, Ji L, Lao S, Powers AS, Zhao W, Erikson JM, Zhang JQ.
    Cardiovasc Res; 2008 Jun 01; 78(3):523-32. PubMed ID: 18252761
    [Abstract] [Full Text] [Related]

  • 36. Combined angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling.
    Mankad S, d'Amato TA, Reichek N, McGregor WE, Lin J, Singh D, Rogers WJ, Kramer CM.
    Circulation; 2001 Jun 12; 103(23):2845-50. PubMed ID: 11401943
    [Abstract] [Full Text] [Related]

  • 37. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.
    Cardiovasc Res; 2005 Jul 01; 67(1):97-105. PubMed ID: 15949473
    [Abstract] [Full Text] [Related]

  • 38. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice.
    Xu J, Carretero OA, Liu YH, Shesely EG, Yang F, Kapke A, Yang XP.
    Hypertension; 2002 Sep 01; 40(3):244-50. PubMed ID: 12215461
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure.
    Suzuki J, Ohta H, Hanada K, Kawai N, Ikeda T, Nakao M, Ikemoto F, Nishikibe M.
    Hypertens Res; 2001 Jan 01; 24(1):65-74. PubMed ID: 11213032
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.